Byotrol (BYOT) Earns Corporate Rating from FinnCap

FinnCap reiterated their corporate rating on shares of Byotrol (LON:BYOT) in a research note issued to investors on Wednesday morning. FinnCap currently has a GBX 9 ($0.13) target price on the stock.

Byotrol stock opened at GBX 2.90 ($0.04) on Wednesday. Byotrol has a 12 month low of GBX 3 ($0.04) and a 12 month high of GBX 6 ($0.08).

In other news, insider David Traynor bought 4,840,628 shares of the company’s stock in a transaction on Wednesday, January 17th. The stock was purchased at an average cost of GBX 3 ($0.04) per share, for a total transaction of £145,218.84 ($205,256.31).

TRADEMARK VIOLATION WARNING: “Byotrol (BYOT) Earns Corporate Rating from FinnCap” was posted by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at

Byotrol Company Profile

Byotrol plc develops, patents, and sells products based on anti-microbial technology in the United Kingdom, North America, and internationally. The company operates through three segments: Professional, Consumer, and Pet. It offers Actizone products, anti-viral hand foams, bathroom cleaners, antimicrobial surface and hand sanitizers, antimicrobial sanitizing wipes, grooming products, multi-purpose cleaners, and multi-surface cleaners.

Receive News & Ratings for Byotrol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Byotrol and related companies with's FREE daily email newsletter.

Leave a Reply